Checkpoint Therapeutics Operating Income

Checkpoint Therapeutics (CKPT) currently reports a operating income of $-56M as of March 2025. That compares with $-45M in the prior-year period — down 25.2% year over year. Use the charts on this page to explore Checkpoint Therapeutics's operating income history and peer comparisons.

Checkpoint Therapeutics's operating income decreased from $-45M to $-56M — a 25.2% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Checkpoint Therapeutics reported $-56M in operating income as of March 2025. That compares with $-45M in the prior-year period — down 25.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-56M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Checkpoint Therapeutics, and consider following CKPT for alerts when major investors trade the stock.

Checkpoint Therapeutics is classified in the Healthcare sector. On operating income, it currently shows $-56M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CKPT with unrelated industries.